These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25255454)

  • 1. Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses.
    Urban SL; Welsh RM
    PLoS Pathog; 2014 Sep; 10(9):e1004357. PubMed ID: 25255454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PKR and Type I IFNs in viral control during primary and secondary infection.
    Nakayama Y; Plisch EH; Sullivan J; Thomas C; Czuprynski CJ; Williams BR; Suresh M
    PLoS Pathog; 2010 Jun; 6(6):e1000966. PubMed ID: 20585572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase PTPN22 has dual roles in promoting pathogen versus homeostatic-driven CD8 T-cell responses.
    Jofra T; Di Fonte R; Hutchinson TE; Dastmalchi F; Galvani G; Battaglia M; Salek-Ardakani S; Fousteri G
    Immunol Cell Biol; 2017 Feb; 95(2):121-128. PubMed ID: 27725666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.
    Lee MS; Park CH; Jeong YH; Kim YJ; Ha SJ
    PLoS Pathog; 2013; 9(7):e1003478. PubMed ID: 23874199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon.
    Marshall HD; Urban SL; Welsh RM
    J Virol; 2011 Jun; 85(12):5929-39. PubMed ID: 21471240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.
    Dudda JC; Salaun B; Ji Y; Palmer DC; Monnot GC; Merck E; Boudousquie C; Utzschneider DT; Escobar TM; Perret R; Muljo SA; Hebeisen M; Rufer N; Zehn D; Donda A; Restifo NP; Held W; Gattinoni L; Romero P
    Immunity; 2013 Apr; 38(4):742-53. PubMed ID: 23601686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of bystander T cell proliferation by viruses and type I interferon in vivo.
    Tough DF; Borrow P; Sprent J
    Science; 1996 Jun; 272(5270):1947-50. PubMed ID: 8658169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
    Wiesel M; Crouse J; Bedenikovic G; Sutherland A; Joller N; Oxenius A
    Eur J Immunol; 2012 Feb; 42(2):320-9. PubMed ID: 22102057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
    Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
    J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA
    Kotzin JJ; Iseka F; Wright J; Basavappa MG; Clark ML; Ali MA; Abdel-Hakeem MS; Robertson TF; Mowel WK; Joannas L; Neal VD; Spencer SP; Syrett CM; Anguera MC; Williams A; Wherry EJ; Henao-Mejia J
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11916-11925. PubMed ID: 31138702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Too much of a good thing: Sustained type 1 interferon signaling limits humoral responses to secondary viral infection.
    Teijaro JR
    Eur J Immunol; 2016 Feb; 46(2):300-2. PubMed ID: 26783074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S; Ou R; Huang L; Moskophidis D
    J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression.
    Zarozinski CC; McNally JM; Lohman BL; Daniels KA; Welsh RM
    J Virol; 2000 Apr; 74(8):3650-8. PubMed ID: 10729141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
    D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
    Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I IFN substitutes for T cell help during viral infections.
    Wiesel M; Kratky W; Oxenius A
    J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
    Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
    PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.
    Shamim M; Nanjappa SG; Singh A; Plisch EH; LeBlanc SE; Walent J; Svaren J; Seroogy C; Suresh M
    J Immunol; 2007 Dec; 179(11):7233-43. PubMed ID: 18025165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.